A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
Clinical trial NCT01381874 · COMPLETED
Trial details
- NCT number
- NCT01381874
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-24
- Primary completion
- 2014-07-28
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.